Specificity: GPRC5A Antibody detects endogenous levels of total GPRC5A.
Host: Rabbit
Application: WB, IHC, IF/ICC
Species Reactivity: Human, Mouse, Rat; Predicted: Pig, Bovine, Horse, Sheep, Rabbit, Dog
Summary
Specifications
Antibody Isotype
IgG
Species Reactivity
Human; Mouse; Rat
Immunogen
A synthesized peptide derived from human GPRC5A, corresponding to a region within the internal amino acids.
Conjugate
Unconjugated
Applications
Application Notes
IHC 1:50-1:200 WB 1:500-1:1000 IF/ICC 1:100-1:500
General Notes
This product (Catalog No. DPABH-02435) is a rabbit-derived polyclonal antibody raised against human GPRC5A. This antibody exhibits cross-reactivity with GPRC5A from mouse and rat. It has been affinity purified by Protein A. This gene encodes a member of the type 3 G protein-coupling receptor family, characterized by the signature 7-transmembrane domain motif. The encoded protein may be involved in interaction between retinoid acid and G protein signalling pathways. Retinoic acid plays a critical role in development, cellular growth, and differentiation. This gene may play a role in embryonic development and epithelial cell differentiation. DPABH-02435 is suitable for use in IHC 1 (50-1:200), WB 1 (500-1:1000), IF/ICC 1 (100-1:500) applications. DPABH-02435 is supplied as a liquid formulation in Phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. For long-term storage, keep at −20 °C. For short-term use, store at 2–8 °C. Avoid repeated freeze–thaw cycles to maintain antibody integrity and performance.
My Review for Rabbit Anti-Human GPRC5A (internal) Polyclonal antibody
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.